Assistant Professor, Radiation Oncology, Perelman School of Medicine
Radiation Oncology
Dr. Ramesh Rengan, MD
|
|
Give Review
Ramesh Rengan is an expert in the field of Radiation Oncology. He went to medical school at University of Michigan Medical School. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Ramesh Rengan is a published doctor. He has 46 papers published. The most current publication "Education and Training Needs in Radiation Oncology in India: Opportunities for Indo-US Collaborations." He accepts Medicare.
Publications
- Education and Training Needs in Radiation Oncology in India: Opportunities for Indo-US Collaborations.
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.
- Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study.
- Intensity-Modulated Proton Therapy for Elective Nodal Irradiation and Involved-Field Radiation in the Definitive Treatment of Locally Advanced Non-Small Cell Lung Canc...
- Stereotactic body radiotherapy.
- Combination of stereotactic ablative body radiation with targeted therapies.
- International Outreach: What Is the Responsibility of ASTRO and the Major International Radiation Oncology Societies?
- Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate.
- Radiation Injury to the Normal Brain Measured by 3D-Echo-Planar Spectroscopic Imaging and Diffusion Tensor Imaging: Initial Experience.
- Stage Migration in Planning PET/CT Scans in Patients Due to Receive Radiotherapy for Non-Small-Cell Lung Cancer.
- Dietary Flaxseed in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation.
- High body mass index is associated with worse quality of life in breast cancer patients receiving radiotherapy.
- Stereotactic body radiation therapy for lung cancer.
- Impact of PET Staging in Limited-Stage Small-Cell Lung Cancer.
- Disparities in the treatment and outcomes of lung cancer among HIV-infected individuals.
- Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study.
- Inhibition of Autophagy as a Strategy to Augment Radiosensitization by the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235.
- Radiation Dosimetry and Biodistribution of the Hypoxia Tracer (18)F-EF5 in Oncologic Patients.
- SU-E-T-437: Interfractional Dosimetric Verification of Lung Patients Treated by Passive Double Scattering Proton Radiotherapy.
- SU-D-211-06: The Effect of Motion in RapidArc Lung SBRT Delivery.
- Brachial Plexopathy in Apical Non-Small Cell Lung Cancer Treated With Definitive Radiation: Dosimetric Analysis and Clinical Implications.
- A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer: A Report of Tox...
- The use of proton therapy in the treatment of lung cancers.
- A moving target: Image guidance for stereotactic body radiation therapy for early-stage non-small cell lung cancer.
- A glimpse of the future: where will new combinations of diagnostics and therapies take us?
- New strategies in non-small cell lung cancer: improving outcomes in chemoradiotherapy for locally advanced disease.
- Adjuvant radiotherapy for completely resected stage 2 thymoma.
- Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma.
- Introduction: non-small-cell lung cancer and pleural malignancies: the end of the era of therapeutic nihilism?
- The role of radiation therapy in malignant thymoma: a Surveillance, Epidemiology, and End Results database analysis.
- Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities a...
- Adjuvant cisplatin and docetaxel for non-small cell lung cancer: the Hospital of the University of Pennsylvania experience.
- Radiotherapy for eyelid, periocular, and periorbital skin cancers.
- Integrating the healthcare enterprise in radiation oncology plug and play--the future of radiation oncology?
- Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques.
- New approaches to radiotherapy as definitive treatment for inoperable lung cancer.
- Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
- Clinical target promiscuity: lessons from ras molecular trials.
- Ten-year results of preoperative radiation followed by sphincter preservation for rectal cancer: increased local failure rate in nonresponders.
- Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection?
- Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer?
- Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer.
- Molecular biology of the Wiskott-Aldrich syndrome.
- Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells.
- Regulation of oscillations in filamentous actin content in polymorphonuclear leukocytes stimulated with leukotriene B(4) and platelet-activating factor.
Schools
University Of Michigan Medical School
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Memorial Sloan-Kettering Cancer Center -
University of Michigan Medical School
Hospital
-
Pennsylvania Hospital -
Philadelphia Veterans Affairs Medical Center -
UW Medicine/Northwest Hospital & Medical Center -
University of Washington Medical Center
Drug Facts
| NPI NUMBER | 1801981428 | |
| NPPES Provider LastName | RENGAN | |
| NPPES Provider FirstName | RAMESH | |
| NPPES Provider ZIPCode | 981338401 | |
| NPPES Provider State | WA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 20.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1801981428 |
| Last Name Of The Provider | RENGAN |
| First Name Of The Provider | RAMESH |
| View All |
Similar Doctors
|
|
Dr. Abigail T. Berman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Natasa C. Townsend, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John J. O'Connell, MD |
|
|
Dr. Lawrence J. Solin, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Keith A. Cengel, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Curtiland Deville Jr., MD
This Doctor is OpenDoctor Recommended.
|